• LG CNS attended CPHI Milan 2026 to expand its manufacturing AI transformation push into pharma and biotech production.
• It showcased an “Autonomous Factory in Pharma” suite spanning digital twin factory design, standardized production data control, and quality analytics.
• The company highlighted AI-driven APQR drafting to support GMP compliance, targeting a more than 90% reduction in preparation time.
• LG CNS was the only South Korean exhibitor in the event’s new “AI & Tech” zone, which drew about 60,000 visitors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LG CNS Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: EN63522) on October 07, 2026, and is solely responsible for the information contained therein.